What is NDC 0143-9262?

0143-9262 is the product NDC for Cefazolin, Cefazolin sodium 330 mg/mL injection, powder, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cefazolin?

42 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cefazolin NDC 0143-9262 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9262Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9262Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9262-25	0014392622500143926225	25 VIAL in 1 CARTON (0143-9262-25) / 3 mL in 1 VIAL (0143-9262-01)Marketed from Sep 18, 2001

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefazolin
Generic name (nonproprietary): cefazolin
Active ingredients: Cefazolin sodium — 330 mg/mL
Dosage form: Injection, Powder, For solution
Route: Intramuscular, Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065047
Marketing start: Sep 18, 2001
Listing expires: Dec 31, 2027
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 0143-9262_0297045b-d3c1-4fe2-8ea4-a690e7c7a886SPL ID 0297045b-d3c1-4fe2-8ea4-a690e7c7a886SPL set ID 26de1ce9-06a9-486f-b27d-2ac635f018d1RxCUI 1665050UNII P380M0454Z
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143926225 followed by a unit qualifier and the quantity

Package 00143-9262-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 14, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cefazolin for Injection, USP is indicated in the treatment of the following serious infections due to susceptible organisms: Respiratory Tract Infections: Due to S. pneumoniae, Klebsiella species, H. influenzae, S. aureus (penicillin-sensitive and penicillin-resistant), and group A beta-hemolytic streptococci . Injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cefazolin for Injection is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of Cefazolin for Injection in the subsequent prevention …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0143-9262

What is NDC 0143-9262?: 0143-9262 is the product NDC for Cefazolin, Cefazolin sodium 330 mg/mL injection, powder, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cefazolin.
What is the active ingredient?: Cefazolin sodium.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cefazolin?: 42 other product NDCs are listed under this name. See all Cefazolin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cefazolin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cefazolin	Cefazolin sodium 2 g/1	Injection, Powder, For solutionIntravenous	Civica, Inc.	72572-054	72572-0054-25
Cefazolincefazolin sodium	Cefazolin sodium 3 g/150mL	Injection, SolutionIntravenous	Baxter Healthcare Corporation	0338-0096	00338-0096-06
Cefazolin	Cefazolin sodium 3 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-845	44567-0845-25
Cefazolin	Cefazolin sodium 3 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Apotex Corp.	60505-6266	60505-6266-05
Cefazolin	Cefazolin sodium 2 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-840	44567-0840-25
Cefazolin	Cefazolin sodium 2 g/1	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9139	00143-9139-25
Cefazolin	Cefazolin sodium 3 g/1	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9140	00143-9140-25
Cefazolin	Cefazolin sodium 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Apotex Corp.	60505-6243	60505-6243-04
Cefazolin	Cefazolin sodium 10 g/1	Injection, Powder, For solutionIntravenous	Apotex Corp.	60505-6244	60505-6244-04
Cefazolin	Cefazolin sodium 2 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Apotex Corp.	60505-6231	60505-6231-05

All 43 Cefazolin NDCs

Other NDCs under ANDA 065047

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065047
Product	Strength	Form · route	Labeler	Product NDC
Cefazolin	Cefazolin sodium 225 mg/mL	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9923
Cefazolin	Cefazolin sodium 330 mg/mL	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9924
Cefazolin	Cefazolin sodium 330 mg/mL	Injection, Powder, For solutionIntramuscular, Intravenous	Henry Schein, Inc.	0404-9834
Cefazolin	Cefazolin sodium 225 mg/mL	Injection, Powder, For solutionIntramuscular, Intravenous	Henry Schein Inc.	0404-9835
Cefazolin	Cefazolin sodium 330 mg/mL	Injection, Powder, For solutionIntramuscular, Intravenous	A-S Medication Solutions	50090-4256
Cefazolin	Cefazolin sodium 330 mg/mL	Injection, Powder, For solutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7027
Cefazolin	Cefazolin sodium 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Civica, Inc.	72572-055